Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


10.12.2018

4 Anticancer Res
3 Biochem Biophys Res Commun
2 BMC Gastroenterol
1 Clin Med Insights Gastroenterol
2 Dig Dis Sci
2 Eur Radiol
13 Hepatology
1 J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. VALAKH V, Gresswell S, Kirichenko A
    Outcomes of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Severe Cirrhosis and Ineligibility for Transplant.
    Anticancer Res. 2018;38:6815-6820.
    PubMed     Text format     Abstract available

  2. MOCHIZUKI K, Kawai M, Odate T, Tahara I, et al
    SMARCB1/INI1 Is Diagnostically Useful in Distinguishing alpha-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:6865-6868.
    PubMed     Text format     Abstract available

  3. WU CY, Jan YJ, Ko BS, Wu YJ, et al
    Prognostic Significance of 14-3-3epsilon, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:6855-6863.
    PubMed     Text format     Abstract available

  4. WAKIYAMA H, Masuda T, Motomura Y, Hu Q, et al
    Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC).
    Anticancer Res. 2018;38:6631-6638.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  5. RUAN W, Pan R, Shen X, Nie Y, et al
    CDH11 promotes liver fibrosis via activation of hepatic stellate cells.
    Biochem Biophys Res Commun. 2018 Nov 30. pii: S0006-291X(18)32585.
    PubMed     Text format     Abstract available

  6. HAN Y, Chen M, Wang A, Fan X, et al
    STAT3-induced upregulation of lncRNA CASC11 promotes the cell migration, invasion and epithelial-mesenchymal transition in hepatocellular carcinoma by epigenetically silencing PTEN and activating PI3K/AKT signaling pathway.
    Biochem Biophys Res Commun. 2018 Nov 29. pii: S0006-291X(18)32516.
    PubMed     Text format     Abstract available

  7. AN MJ, Kim DH, Kim CH, Kim M, et al
    Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells.
    Biochem Biophys Res Commun. 2018 Dec 1. pii: S0006-291X(18)32614.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  8. CHAN KM, Tsai CY, Yeh CN, Yeh TS, et al
    Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence.
    BMC Gastroenterol. 2018;18:180.
    PubMed     Text format     Abstract available

  9. GAO F, Li X, Wan G, Li Y, et al
    Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis.
    BMC Gastroenterol. 2018;18:179.
    PubMed     Text format     Abstract available


    Clin Med Insights Gastroenterol

  10. DE MELLO CL, da Conceicao TMA, Dal Pont T, Peruzzolo CC, et al
    The Benefits of Neuromuscular Electrical Stimulation in the Muscular and Functional Capacity of Patients With Liver Cirrhosis: Protocol for a Randomized Clinical Trial.
    Clin Med Insights Gastroenterol. 2018;11:1179552218811834.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  11. TOLBOL KS, Stierstorfer B, Rippmann JF, Veidal SS, et al
    Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5395.
    PubMed     Text format     Abstract available

  12. PINERO F, Rubinstein F, Marciano S, Fernandez N, et al
    Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5390.
    PubMed     Text format     Abstract available


    Eur Radiol

  13. CHA DI, Kang TW, Song KD, Lee MW, et al
    Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5868.
    PubMed     Text format     Abstract available

  14. TSAUO J, Zhao H, Zhang X, Ma H, et al
    Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5840.
    PubMed     Text format     Abstract available


    Hepatology

  15. ALVES-BEZERRA M, Li Y, Acuna M, Ivanova AA, et al
    Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids into Triglyceride Biosynthesis.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30411.
    PubMed     Text format     Abstract available

  16. LAW CT, Wei L, Tsang FH, Chan CY, et al
    HELLS regulates chromatin remodeling and epigenetic silencing of multiple tumor suppressor genes in human hepatocellular carcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30414.
    PubMed     Text format     Abstract available

  17. SIMONETTO DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, et al
    Management of Sepsis in Patients with Cirrhosis: current evidence and practical approach.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30412.
    PubMed     Text format     Abstract available

  18. MA Y, Yang W, Simon TG, Smith-Warner SA, et al
    Dietary patterns and risk of hepatocellular carcinoma among US men and women.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30362.
    PubMed     Text format     Abstract available

  19. FANG JH, Xu L, Shang LR, Pan CZ, et al
    Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30366.
    PubMed     Text format     Abstract available

  20. GIOIA S, Nardelli S, Riggio O
    Liver stiffness in non-cirrhotic portal hypertension - The Devil is in the diagnosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30367.
    PubMed     Text format     Abstract available

  21. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    PubMed     Text format     Abstract available

  22. KHAMBU B, Li T, Yan S, Yu C, et al
    Hepatic Autophagy Deficiency Compromises FXR Functionality and Causes Cholestatic Injury.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30407.
    PubMed     Text format     Abstract available

  23. HUCK I, Gunewardena S, Espanol-Suner R, Willenbring H, et al
    Hepatocyte Nuclear Factor 4 alpha (HNF4alpha) Activation is Essential for Termination of Liver Regeneration.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30405.
    PubMed     Text format     Abstract available

  24. BALE R, Schullian P, Eberle G, Putzer D, et al
    Stereotactic radiofrequency ablation of hepatocellular carcinoma - A histopathological study in explanted livers.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30406.
    PubMed     Text format     Abstract available

  25. MO DC, Jia RR, Zhong JH
    Hepatic Resection Compared to Chemoembolization in Intermediate to Advanced-Stage HCC: a comment for moving forward.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30409.
    PubMed     Text format     Abstract available

  26. HUANG L, Cai J, Guo H, Gu J, et al
    ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30404.
    PubMed     Text format     Abstract available

  27. CLARIA J, Moreau R, Fenaille F, Amoros A, et al
    Orchestration of Tryptophan-Kynurenine pathway, acute decompensation and acute-on-chronic liver failure in cirrhosis.
    Hepatology. 2018 Dec 6. doi: 10.1002/hep.30363.
    PubMed     Text format     Abstract available


    J Gastroenterol

  28. RAKSAYOT M, Chuaypen N, Khlaiphuengsin A, Pinjaroen N, et al
    Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    J Gastroenterol. 2018 Nov 30. pii: 10.1007/s00535-018-01533.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: